BENEFICIAL EFFECT OF CILOSTAZOL OVERCOMING ADVERSE SMOKING OUTCOMES IN PATIENTS WITH DRUG-ELUTING STENT IMPLANTATION: ANALYSIS OF LONGER-TERM FOLLOW-UP OF THE CILON-T RANDOMIZED TRIAL
2014; Elsevier BV; Volume: 63; Issue: 12 Linguagem: Inglês
10.1016/s0735-1097(14)61523-0
ISSN1558-3597
AutoresHack‐Lyoung Kim, Jung‐Won Suh, Seung‐Pyo Lee, Hyun‐Jae Kang, Bon‐Kwon Koo, Young‐Seok Cho, Tae‐Jin Youn, In‐Ho Chae, Dong‐Ju Choi, Seung‐Woon Rha, Jang‐Ho Bae, Taek‐Geun Kwon, Jang‐Whan Bae, Myeong‐Chan Cho, Hyo-Soo Kim,
Tópico(s)Coronary Interventions and Diagnostics
ResumoThe aim of the study was to investigate whether cilostazol can overcome adverse effect of smoking on clinical outcomes after percutaneous coronary intervention (PCI). A total of 914 patients with successful drug-eluting stent (DES) implantation were randomly assigned to dual antiplatelet therapy (
Referência(s)